Thermo Fisher Scientific (TMO) Declares $0.15 Quarterly Dividend; 0.3% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/2/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- DataMeds AI's Corexa Pharmacy tops $1M in monthly revenue
- Equities rebound to close higher as surging Treasury yields recede
- onsemi cuts Synaptics deal price to $5.7B after rival bid
- Wells Fargo names 13 stocks as overweight tactical ideas
- Twilio, Vylor set to join S&P 500 as index reshuffles members
Evoke Pharma (EVOK) Signs Commercial Deal with with Thermo Fisher Scientific for Gimoti
November 9, 2017 8:31 AM ESTEvoke Pharma, Inc. (NASDAQ: EVOK) announced the selection of the Patheon division of Thermo Fisher Scientific (NYSE: TMO), as the commercial manufacturing partner for Gimoti, Evokes nasal delivery formulation of metoclopramide for the relief of symptoms associated with acute and... More
